SUMMARY
The current knowledge about heat nociception is mainly confined to the thermosensors, including the transient receptor potential cation channel V1 expressed in the nociceptive neurons of dorsal root ganglion (DRG). However, the loss of thermosensors only partially impairs heat nociception, suggesting the existence of undiscovered mechanisms. We found that the loss of an intracellular fibroblast growth factor (FGF), FGF13, in the mouse DRG neurons selectively abolished heat nociception. The noxious heat stimuli could not evoke the sustained action potential firing in FGF13-deficient DRG neurons. Furthermore, FGF13 interacted with the sodium channel Na v 1.7 in a heat-facilitated manner. FGF13 increased Na v 1.7 sodium currents and maintained the membrane localization of Na v 1.7 during noxious heat stimulation, enabling the sustained firing of action potentials. Disrupting the FGF13/Na v 1.7 interaction reduced the heat-evoked action potential firing and nociceptive behavior. Thus, beyond the thermosensors, the FGF13/Na v 1.7 complex is essential for sustaining the transmission of noxious heat signals.
INTRODUCTION
Fibroblast growth factors (FGFs) are classified into secretory (FGF1-10 and FGF15-23) or intracellular, non-secretory forms (FGF11-14) (Guillemot and Zimmer, 2011; Zhang et al., 2012) . Secretory FGFs are known for their functions in neural development, but knowledge about intracellular FGFs remains limited (Guillemot and Zimmer, 2011; Zhang et al., 2012) . FGF13 is an intracellular FGF expressed in the nervous system (Hartung et al., 1997) . It is transiently expressed in cortical neurons during brain development but maintains high-level expression from development to adulthood in the dorsal root ganglion (DRG) (Hartung et al., 1997; Li et al., 2002 ). FGF13 has two major alternative splicing isoforms, i.e., FGF13A and FGF13B. FGF13A contains the nucleus localization signal, while FGF13B is distributed in the cytoplasm and contributes to dynamic signaling processes .
Noxious stimuli (e.g., thermal, mechanical, and chemical) cause pain by activating cutaneous Ad and C nociceptors, the peripheral terminals of small-diameter DRG neurons. Our recent neuron-typing study analyzed the transcriptome and functions of DRG neurons, and at least six types of mechanoheat nociceptors (MHNs) were identified (Li et al., 2016) . The transduction of nociceptive signals involves special membrane proteins sensitive to a particular stimulus. For instance, the transient receptor potential cation channel V1 (TRPV1) expressed in small DRG neurons serves as a thermosensor (>42 C). However, the TRPV1 gene knockout mice only showed a partial reduction of the nociceptive behaviors induced by intense heat stimuli (>52 C) and did not exhibit apparent reduction in response to noxious heat stimuli below 48 C (Caterina et al., 2000; Davis et al., 2000) , suggesting the existence of undiscovered mechanisms for heat nociception.
The transduction of nociceptive signals also requires voltagegated sodium (Na v ) channels, which are critical for the generation of action potentials (APs). Of the nine a subunits of Na v channels (Catterall et al., 2005) , Na v 1.6, Na v 1.7, Na v 1.8, and Na v 1.9 are expressed in DRG neurons and contribute to somatosensory signal transmission (Dib-Hajj et al., 2010) . Particularly, the tetrodotoxinsensitive (TTX-S) Na v 1.7 is critical to nociception (Dib-Hajj et al., 2013; Lee et al., 2014) . In humans, gain-of-function mutations of Na v 1.7 lead to severe thermal hyperalgesia (Dib-Hajj et al., 2005; Fertleman et al., 2006; Yang et al., 2004) , while loss-of-function mutations of Na v 1.7 result in complete insensitivity to noxious stimuli (Cox et al., 2006; Emery et al., 2015) . A recent study on Na v 1.7 gene knockout mice confirmed the requirement of Na v 1.7 in nociception (Gingras et al., 2014) . Furthermore, knockdown of Na v 1.7 attenuates complete Freund's adjuvant (CFA)-induced thermal hyperalgesia (Yeomans et al., 2005) . Deletion of Na v 1.7 in mouse DRG neurons impairs acute nociception and inflammation-and burn injury-induced thermal hyperalgesia (Minett et al., 2012; Nassar et al., 2004; Shields et al., 2012) . Intracellular FGFs may interact with Na v channels and modulate the gating properties and current densities of sodium channels. FGF12 interacts with Na v 1.5 and Na v 1.9 (Liu et al., 2001 (Liu et al., , 2003 . In hippocampal and cerebellar neurons, FGF14 is localized at the initial segment of axons and interacts with Na v 1.1, Na v 1.2, and Na v 1.6 (Laezza et al., 2007 (Laezza et al., , 2009 Lou et al., 2005; Xiao et al., 2013) . The genetic ablation of Fgf12 and Fgf14 in mice results in ataxia and paroxysmal dystonia (Goldfarb et al., 2007; Wang et al., 2002) and impairs neurotransmission in the hippocampus (Xiao et al., 2007) . FGF13 co-localizes with Na v 1.6 at the Ranvier nodes along the myelinated nerve fibers, and FGF13 overexpression increases the sodium current density in ND7/23 cells (Wittmack et al., 2004) . We have shown that FGF13 is expressed in small DRG neurons (Li et al., 2002) . However, its function in somatosensation remains unknown.
Here, we reveal a role of FGF13 in noxious heat sensation in mice. The FGF13 deletion in DRG neurons selectively abolished heat nociception and reduced the heat-evoked neuronal firing. FGF13 interacted with Na v 1.7, and this heat-facilitated interaction maintained the cell membrane localization of Na v 1.7, enabling the heat-evoked AP firing. Disrupting the FGF13/Na v 1.7 interaction reduced both heat-induced AP firing and nociceptive behavior. Thus, our study provides a molecular mechanism essential for heat nociception beyond thermosensors.
RESULTS

FGF13 Is Expressed in Mechanoheat Nociceptive Neurons
We first examined the FGF13 expression profile in the nervous systems of adult mice by immunoblotting and found that FGF13 was abundant in the DRG ( Figure S1A ). Immunostaining showed that FGF13 was present in 83.4% ± 4.3% (n = 3 mice) of small DRG neurons ( Figure 1A ; Figure S1B ). FGF13 was present in both the dorsal root and the sciatic nerve ( Figure S1C ), suggesting that FGF13 synthesized in somata of DRG neurons is transported to their central and peripheral terminals. Double immunostaining showed that 60.6% ± 6.6% of calcitonin generelated peptide (CGRP)-positive neurons (n = 3 mice, 100-200 neurons per mouse) and 86.1% ± 3.2% of isolectin B4 (IB4)-positive neurons (n = 3 mice, 100-200 neurons per mouse) expressed FGF13 ( Figure S1D ). FGF13 was also detected in the DRG afferent fibers in the laminae I-II of spinal cord (SC), where C and Ad fibers terminate, as well as efferent fibers in the glabrous skin ( Figure 1A ; Figure S1E ).
We used single-cell RNA sequencing and electrophysiological recording to categorize DRG neuron types (Li et al., 2016) and found that FGF13 was highly expressed in five types of MHNs (C1, C2, C4, C5, and C6) ( Figure S1F ) (Li et al., 2016) . Na v 1.7, Na v 1.8, and Na v 1.9 were also expressed in these neuron types, while TRPV1 was mainly expressed in C1 and C2 ( Figure S1F ). The co-expression of Na v 1.7 and Na v 1.8 in DRG neurons was confirmed with dual fluorescent in situ hybridization (81.8% ± 0.5% of Na v 1.7 mRNA-expressing neurons contained Na v 1.8 mRNA and 95.0% ± 0.3% of Na v 1.8 mRNA-expressing neurons contained Na v 1.7 mRNA, n = 3 mice, 100-200 neurons per mouse) ( Figure S1G ).
Loss of FGF13 Selectively Abolishes Noxious Heat Sensation
To determine the FGF13 function, we deleted FGF13 gene (Fgf13) in small DRG neurons by crossing homozygous Fgf13-flox mice with a bacterial artificial chromosome (BAC) transgenic mouse line expressing Cre recombinase controlled by promoter elements of the Na v 1.8 gene (SNS-Cre) (Agarwal et al., 2004) ( Figure S2A Figures 1A and 1B ). There were no apparent changes in the total number and morphology of DRG neurons ( Figures S2B and S2C ), the structure of their fibers and synapses in the dorsal spinal cord, or their nerve innervation in the skin ( Figures S2D-S2G ). The synaptic transmission from the DRG to dorsal spinal cord neurons was stimulation (n = 14 in the tail-flick test; n = 10 in the Hargreaves test; n = 13 for F/Y and n = 14 for À/Y in the hot plate test). In the CFA-induced inflammatory pain model, F/Y mice show hyperalgesic responses to radiant noxious heat applied to the plantar skin. À/Y mice do not show hyperalgesia (n = 12 for F/Y and n = 14 for À/Y) (F). All the tests were stopped at the cutoff (C.O.) time if the animal did not respond.
(G) The two-temperature choice test shows that À/Y mice exhibit normal sensitivity to innocuous temperatures (n = 12-20 for F/Y and n = 8-15 for À/Y) (left). À/Y mice are less sensitive to noxious heat conditions than F/Y mice, but À/Y mice exhibit normal sensitivity to noxious cold (n = 9 for F/Y and n = 7 for À/Y) (right).
(H) The fMRI activation maps describe brain activity in response to noxious heat (47.5 C) stimulation applied to the left hindpaw of mice. The top and middle rows
show fMRI activation maps of F/Y (n = 16) and À/Y (n = 15) mice, respectively. The bottom row shows the statistical difference map overlaid with a mouse atlas for the identification of brain regions with altered noxious heat responsiveness. Scale bar, t value range. L, left; R, right; d, dorsal; v, ventral; Amyg, amygdala; CPu, caudate nucleus and putamen (striatum); HPC, hippocampus; Ins, insular cortex; MD, mediodorsal nuclei of thalamus; PAG, periaqueductal gray; PF, parafascicular nuclei of thalamus; RSG, retrosplenial granular cortex; S1 and S2, the primary and secondary somatosensory cortices. also normal ( Figure S2H Figure 1D ). In the hot plate test, at 50 C, 52 C, or 55 C (with cutoff time of 70 s, 50 s, or 30 s, respectively), the mutant mice did not respond to the heat stimulation (Figure 1E) Figure S3C ). In the two-temperature choice test, Fgf13 À/Y mice tended to choose the innocuous warm temperature (30 C) and avoid noxious cold (5 C and 15 C) or noxious heat (48 C and 55 C), suggesting that they were able to distinguish different temperatures; yet, their tolerance to noxious heat was increased ( Figure 1G ). Fgf13 À/Y mice exhibited normal mechanical nociceptive responses in both the von Frey and Randall-Selitto (tail clip) tests ( Figure S3D ). We used formalin test to examine the chemical nociception and found that Fgf13 À/Y mice, like wild-type mice, exhibited two-phase nociceptive responses, but the phase II was delayed without changes in its peak level ( Figure S3E ), suggesting that chemical nociception was mildly changed. Moreover, FGF13-deficient mice showed normal locomotor functions in rotarod and open field tests (Figures S3F and S3G) . Furthermore, microarray analysis showed no prominent change (>2-fold change, p < 0.05, n = 3) in mRNA levels of other FGFs, sodium channels, thermosensors-such as TRP channels (Caterina et al., 2000; Davis et al., 2000) -and anoctamin 1 (Ano1) (Cho et al., 2012) in the DRG of Fgf13 À/Y mice (Figure S3H) . This is consistent with the result of semiquantitative reverse transcription PCR (RT-PCR) ( Figure S3I ). However, the protein levels of Na v 1.8 and TRPV1 were elevated in the DRG of Fgf13 À/Y mice ( Figure S4A ), suggesting a compensatory reaction in the mutant mice. Whole-cell patch-clamp recording showed that both the percentage of small DRG neurons sensitive to TRPV1 agonist capsaicin and the amplitude of capsaicin-induced current were increased ( Figure S4B ). Therefore, Fgf13 À/Y mice exhibit a selective loss of heat nociception despite the compensatory increase of TRPV1 function.
Noxious Heat-Induced Brain fMRI Activities Are Eliminated in Fgf13 -/Y Mice
In Fgf13 F/Y mice, noxious heat stimuli (47.5 C) applied to the surface of left hindpaw elicited robust fMRI activation across the brain, but these stimuli elicited limited activation and more negative signals in Fgf13 À/Y mice ( Figure 1H ). To determine the mostaffected brain regions, we compared the activation maps between the Fgf13 F/Y and the Fgf13 À/Y groups and described the response differences in a statistical difference map ( Figure 1H ). The FGF13 deficiency eliminated the majority of noxious heat-evoked responses. The primary (S1) and secondary (S2) somatosensory, retrosplenial granular (RSG), and insular (Ins) cortices, as well as the amygdala (Amyg), the periaqueductal gray (PAG), the striatum (caudate nucleus and putamen, CPu), the CA1 region of hippocampus (HPC), and the mediodorsal (MD) and parafascicular (PF) nuclei of thalamus showed different responses between two groups. Many of these brain regions are known to be involved in nociception (Treede et al., 1999 Figure 1J ). FGF13 deficiency affected the Amyg to the greatest degree, followed by the CPu, Ins, S2, and RSG. The S1 cortex exhibited the smallest difference in the magnitude ( Figure 1K , n = 39) ( Figure 2B ). We analyzed the distribution pattern of APs through the percentage of AP numbers at each degree. In small DRG neurons of Fgf13 F/Y mice, the AP firing rate started to accelerate at $42 C, reached maximum at 43 C, and remained at that level to 45 C (Figures 2A, 2C , and 2D). In contrast, the AP firing in small DRG neurons of Fgf13 À/Y mice gradually decreased in response to temperature elevation and tended to cease at 45 C (Figures 2A, 2C , and 2D). Moreover, the AP amplitude was relatively uniform following the all-or-none rule in Fgf13 
Fgf13
À/Y neurons ( Figure 2E ). When normalized to the amplitude of the first AP, AP amplitude at 45 C was 66.2% ± 0.06% in Fgf13 F/Y neurons (n = 16) and 9.3% ± 0.05% in Fgf13 À/Y neurons (n = 14) ( Figure 2F ). The heat-induced attenuation of AP firing in Fgf13 À/Y neurons was not caused by impaired neuronal responsiveness because APs were efficiently triggered by current injection after the heat stimulation ( Figure S5A ). Therefore, FGF13-deficient small DRG neurons exhibit attenuated AP firing during noxious heat stimulation, although they are capable of detecting thermal changes below 42 C. To further evaluate the distinct roles of FGF13 and TRPV1 in noxious heat sensation, we examined heat-induced AP firing in TRPV1-deficient DRG neurons for comparison. The percentage of heat-sensitive small DRG neurons (35.2%, n = 71 wild-type neurons) was decreased in Trpv1 knockout (Trpv1 À/À ) mice (16.1%, n = 78) ( Figure 2B ). However, the remaining heat-sensitive neurons responded to heat stimuli with an accelerating frequency and an evenly distributed amplitude in a manner that was similar to that of wild-type neurons ( Figures 2C-2F ). The AP amplitude at 45 C was reduced to 62.5% ± 0.12% in TRPV1-deficient neurons (n = 11), similar to that in wild-type neurons (p = 0.77). Thus, although more than half of the DRG neurons lost the responsiveness to heat stimuli in Trpv1 (Schwarze et al., 1999) (GST-FGF13B-TAT). GST-FGF13B-TAT incubation (1 mM for 120 min) reversed the reduced AP firing during noxious heat stimulation in Fgf13 À/Y DRG neurons; the AP amplitude at 45 C returned to 64.5% ± 0.06% of the initial AP amplitude (n = 13) (Figures 2A and 2C-2F ). In contrast, the control protein GST-TAT did not have the same rescue effect (Figures 2C-2F ).
The proportions of neurons responding to noxious heat were similar among all experimental groups ( Figure S5B ). These results indicate that FGF13 is essential for the persistent AP firing of small DRG neurons during noxious heat stimulation.
To study the in vivo effects of the exogenous FGF13, we first applied GST-FGF13B-TAT intrathecally (i.t.) to C57BL/6 mice and tested its metabolic kinetics. The peak level of GST-FGF13B-TAT in both the DRG and dorsal spinal cord was detected 20-60 min after injection ( Figure 2G ). Immunoblotting showed that the amount of the exogenous FGF13 with GST ($45 kDa) was much less than that of the endogenous FGF13 ($20 kDa), so GST-FGF13B-TAT effects would not be caused by an overdose ( Figure S5C ). Then, we applied GST-FGF13B-TAT (i.t.) to Fgf13 À/Y mice. GST-FGF13B-TAT, but not GST-TAT, rescued the heat sensitivity of Fgf13 À/Y mice within an effective period after injection ( Figure 2H ). Immunoblotting showed that GST-FGF13B-TAT (i.t.) could be detected in both the DRG and the plantar skin of hindpaw ( Figure S5D FGF13 Directly Interacts with Na v 1.7 Dual fluorescent in situ hybridization and single-cell RNA sequencing showed the co-expression of FGF13 and Na v 1.7 ( Figure 3A ; Figure S1F ). Namely, 71.8% ± 4.1% of FGF13-positive neurons (n = 3 mice, 100-200 neurons per mouse) contained Na v 1.7, while 80.1% ± 1.6% of Na v 1.7-positive neurons (n = 3 mice, 100-200 neurons per mouse) expressed FGF13. The majority of FGF13-containing neurons (78.1% ± 4.4%, n = 3 mice, 100-200 neurons per mouse) also expressed Na v 1.8 (Figure S6A) . To identify the underlying mechanism of the change in AP firing in FGF13-deficient DRG neurons, we examined the interactions between FGF13 and Na v channels in the DRG (i.e., Na v 1.6, Na v 1.7, Na v 1.8, and Na v 1.9) using co-immunoprecipitation (IP) and GST pull-down methods. In co-IP experiments with mouse DRG protein extract, FGF13 showed a potent interaction with Na v 1.7 and a relatively weak interaction with Na v 1.6, while FGF13 barely interacted with Na v 1.8 or Na v 1.9 ( Figure 3B ; Figures FGF13 exhibited strong interaction with Na v 1.7 but much weaker interaction with Na v 1.8 ( Figure 3C ; Figure S6E ). Interaction between the exogenous FGF13 (i.t.) and the endogenous Na v 1.7 in the DRG and spinal dorsal horn was also detected ( Figure 2G ). Notably, the most potent interaction appeared 20-60 min after GST-FGF13B-TAT injection, consistent with the period of its best rescue effects on Fgf13 À/Y mice ( Figures 2G and 2H) . Moreover, we did not detect any apparent interaction between FGF13 and TRPV1 or TRPV2, two TRP channels that are activated by temperatures above 42 C or 52 C, respectively (Figures S6F and S6G) . Thus, FGF13 interacts with Na v 1.7 in DRG neurons, while its interactions with TRPV1 or TRPV2 are not detectable.
Furthermore, we identified an FGF13-binding region in the C terminus of Na v 1.7 (Na v 1.7CT). Intracellular FGFs have been predicted to interact with the C-terminal region of Na v channels (Goetz et al., 2009 ). We constructed a plasmid encoding a fusion protein myc-CD8a-Na v 1.7CT, in which Na v 1.7CT was anchored to the cell membrane via myc-CD8a; myc-CD8a-Na v 1.7CT, but not myc-CD8a, was co-immunoprecipitated with FGF13 (Figure 3D) . To determine the precise binding region for FGF13, we made a series of truncated Na v 1.7CT proteins fused with GST ( Figure 3E ). A GST pull-down assay showed a direct interaction between the purified FGF13 and Na v 1.7CT, and the 1,876-1,896 aa in Na v 1.7CT was the major binding site for FGF13 ( Figure 3F ). On the other hand, it seemed that FGF13 did not contain a specific region mediating its interaction with Na v 1.7CT because only full-length FGF13 bound to Na v 1.7CT ( Figure S6H ). We assume that the tertiary structure of the full-length FGF13 is critical for its interaction with Na v 1.7CT. Thus, FGF13 directly interacts with the C terminus of Na v 1.7.
FGF13 Increases Na v 1.7 Current Density Because FGF13 interacted with Na v 1.7, FGF13 might regulate the function of Na v 1.7. We recorded the sodium currents evoked by a step depolarization (À90 mV to 50 mV in 5 mV increments) in HEK293 cells co-transfected with Na v 1.7 and FGF13B-IRES-GFP. We analyzed the current density and the voltage dependence of Na v 1.7 activation. In comparison with the control IRES-GFP vector, FGF13B-IRES-GFP expression increased Na v 1.7 current densities without an apparent shift in the voltage dependence of Na v 1.7 activation (Na v 1.7 and vector: V 50 = À17.5 ± 2.1 mV, n = 16; Na v 1.7 and FGF13B: V 50 = À22.2 ± 2.2 mV, n = 17; p = 0.14) ( Figures 4A-4C ). We also analyzed the fast inactivation of Na v 1.7 by measuring peak sodium currents induced at À10 mV after a series of 500 ms prepulses stepping from À130 mV to À10 mV in 5 mV increments. The voltage dependence of Na v 1.7 inactivation was not changed (Na v 1.7 and vector: V 50 = À75.2 ± 1.2 mV, n = 15; Na v 1.7 and FGF13B: V 50 = À72.8 ± 1.1 mV, n = 17; p = 0.15) ( Figure 4C ). Thus, FGF13 increases the Na v 1.7 current density without altering its activation/inactivation properties.
Then, we examined the sodium currents in FGF13-deficient small DRG neurons by a step depolarization (À90 mV to 50 mV in 5 mV increments). FGF13 deficiency reduced the TTX-S sodium currents without affecting the voltage dependence of channel activation (Fgf13 Because temperature affects sodium currents (Arrigoni et al., 2016; Han et al., 2007) , we then recorded the sodium currents of small DRG neurons at innocuous (30 C) and noxious (45 C) temperatures ( Figure 4G ). The sodium currents were lower in Fgf13 À/Y neurons than in Fgf13 F/Y neurons at both temperatures. Notably, the sodium currents of Fgf13 À/Y neurons were even lower at 45 C than at 30 C, indicating a correlation between the decreased sodium current and the attenuated AP firing in FGF13-deficient neurons during noxious heat stimulation. In contrast, the sodium currents of Fgf13 F/Y neurons were not changed by increased temperature ( Figure 4G ). Taken together, these findings show that FGF13 increases the current density of Na v 1.7 and therefore maintains the excitability of small DRG neurons, especially in noxious heat conditions. FGF13/Na v 1.7 Interaction Is Facilitated by Heat Stimulation and Maintains Na v 1.7 Level in Cell Membrane Given that FGF13 was critical for the maintenance of sodium currents and neuronal excitability in noxious heat condition, we further investigated the underlying mechanism. We assumed that the availability of sodium channels might decrease during heat stimulation. The cultured DRG neurons of Fgf13 F/Y and Fgf13 À/Y mice were treated with a water bath at 43 C for 30 s or 1 min and then immediately cooled down on ice, such that Na v 1.7 trafficking was restrained, and the instantaneous localization of Na v 1.7 was maintained. Then, the membrane proteins were examined by biotinylation and immunoblotting ( Figure 5A ). We did not detect heat-induced changes in the Na v 1.7 level in the plasma membrane of Fgf13 F/Y neurons. However, the membrane Na v 1.7 level decreased in Fgf13 À/Y neurons after heat treatment ( Figure 5B ). The membrane Na v 1.7 level was not affected by the Fgf13 knockout without heat stimuli ( Figure 5B ). (A) Dual fluorescent in situ hybridization shows the coexistence of FGF13 and Na v 1.7 mRNA in DRG neurons (arrows). Scale bar, 50 mm.
(B) Co-IP shows that FGF13 interacts with Na v 1.7 in the DRG and SC. The FGF13/Na v 1.7 interaction level is higher than the interaction levels between FGF13 and other sodium or TRP channels (n = 3-6).
(C) A GST pull-down assay shows that GST-FGF13B protein interacts with Na v 1.7. The interaction between GST-FGF13B and Na v 1.8 is much weaker (n = 3).
(D) The C terminus of Na v 1.7 (Na v 1.7CT) was fused to myc-CD8a, which anchors Na v 1.7CT to the cell membrane. Co-IP shows that FGF13 interacts with Na v 1.7CT fused to myc-CD8a, but not with myc-CD8a. (E) A schematic illustration of GST-flag-Na v 1.7CT truncations. Na v 1.7CT was truncated into nine fragments to search for the FGF13-binding site. The position of the major binding site f8 is marked in red.
(F) A GST pull-down assay with two purified proteins, GST-flag-Na v 1.7CT and FGF13B, shows the direct interaction between FGF13 and Na v 1.7. The major interaction site is f8 (1,876-1,896 aa) of Na v 1.7CT (n = 4). The data are shown as mean ± SEM; *p < 0.05, **p < 0.01, and ***p < 0.001 versus the indicated group. See also Figure S6 .
Thus, in the absence of FGF13, the amount of Na v 1.7 in the plasma membrane of DRG neurons decreases after noxious heat stimulation, indicating a requirement of FGF13 for maintaining Na v 1.7 density in the cell membrane. Next, we wondered whether the FGF13/Na v 1.7 interaction was dynamic in noxious heat conditions. We collected HEK293 cells transfected with the plasmids expressing FGF13B and Na v 1.7 and added the membrane-permeant reagent disuccinimidyl suberate (DSS) to chemically crosslink FGF13 with the Na v 1.7 present in the membrane and the cytosol ( Figure 5C ). Using immunoblotting, we identified an extra FGF13-containing band with a large molecular weight (>250 kDa, approximately the sum of the molecular weights of FGF13 and Na v 1.7) after crosslinking ( Figure 5D ), suggesting the formation of the FGF13/Na v 1.7 complex. Then, we used surface biotinylation and immunoblotting to examine how the FGF13/Na v 1.7 complexes associated with the cell membrane were affected by heat treatment. To estimate the formation of FGF13/Na v 1.7 complex during heat stimulation, we performed the DSS crosslinking before and after the heat treatment ( Figure 5C ). We found that the FGF13/Na v 1.7 complex could be detected in both the plasma membrane and the whole-cell lysate and that the heat stimulation facilitated the complex formation ( Figure 5D ). The heat-induced formation of the FGF13/Na v 1.7 complex was also detected in DRG neurons ( Figure 5E ). Furthermore, we enriched the membrane component of HEK293 cells expressing The I-V curve shows the Na v 1.7 current density in HEK293 cells is enhanced by FGF13B (n = 16 for Na v 1.7 + vector and n = 17 for Na v 1.7 + FGF13B). (C) The voltage dependence of Na v 1.7 activation and inactivation in HEK293 cells is not changed by FGF13B (activation: n = 16 for Na v 1.7 + vector and n = 17 for Na v 1.7 + FGF13B; inactivation: n = 15 for Na v 1.7 + vector and n = 17 for Na v 1.7 + FGF13B). FGF13 and Na v 1.7 (as functional FGF13/Na v 1.7 complex was supposed to be in the cell membrane) after the FGF13/Nav1.7 interaction was trapped during heat stimulation with crosslinking reagent. After removing free-binding FGF13 and Na v 1.7 using high detergent condition and repeated washing procedures in co-IP assay, we detected the enhanced FGF13/Na v 1.7 interaction that was trapped during heat stimulation ( Figure 5F ; Figure S7A ). The heat-facilitated FGF13/Na v 1.7 interaction may stabilize Na v 1.7 channels in the cell membrane during noxious heat stimulation. We have shown that FGF13 acts as a microtubule-stabilizing protein that is required for the migration of cortical neurons during brain development . We found that the heat-facilitated formation of the FGF13/Na v 1.7 complex was not attenuated by the disruption of actin filaments or microtubules with cytochalasin D or nocodazole, respectively ( Figure S7B ). This suggests that the cytoskeleton-mediated transport system is not involved in the heat-facilitated FGF13/ Na v 1.7 interaction. FGF13 and Na v 1.7 might localize closely and rapidly form the complex required for the stabilization of Na v 1.7 in the cell membrane.
Disrupting FGF13/Na v 1.7 Interaction Attenuates Noxious Heat Sensation To confirm the contribution of the FGF13/Na v 1.7 complex to noxious heat-induced neuronal excitability, we prepared membrane-permeable GST-flag-Na v 1.7CT-TAT (Na v 1.7CT-TAT) as a competitive peptide to block the endogenous interaction between FGF13 and Na v 1.7 ( Figures 6A and 6B ). In cultured DRG neurons, the co-IP signal of the FGF13/Na v 1.7 interaction was decreased after a 30 min treatment with 1 mM Na v 1.7CT-TAT ( Figure 6B ). Thus, Na v 1.7CT-TAT is able to competitively block the FGF13/Na v 1.7 interaction in DRG neurons.
Then, we analyzed the effect of Na v 1.7CT-TAT on AP firing following the heat stimulation in small DRG neurons of C57BL/6 mice. In neurons incubated with 1 mM Na v 1.7CT-TAT (n = 16), the APs showed two patterns. In one pattern, the AP amplitude at 45 C decreased to 20.6% ± 0.08% of the initial AP, and the decay level was much greater than that of the control group treated with GST-flag-TAT (81.1% ± 0.06%, n = 12) (Figures 6C and 6D) . In another firing pattern, few AP spikes were evoked by the heat stimulation ( Figures 6C and 6D) . Na v 1.7CT-TAT did not alter the firing of small DRG neurons from Fgf13 À/Y mice ( Figure 6D) . Therefore, the AP firing of small DRG neurons treated with Na v 1.7CT-TAT was attenuated during heat stimulation, which was similar to the change observed in FGF13-deficient small DRG neurons (Figures 2A-2F) . Furthermore, the heat-induced AP firing was reduced in small DRG neurons treated with 10 nM Protoxin-II, a Na v 1.7 inhibitor (Schmalhofer et al., 2008) , and the decay of heat-induced AP amplitude was similar to that in neurons lacking FGF13 or treated with Na v 1.7CT-TAT ( Figure 6D) . Thus, the FGF13/Na v 1.7 interaction is essential for the maintenance of neuronal excitability in response to noxious heat stimuli.
We further examined the effect of Na v 1.7CT-TAT on behavioral responses to noxious heat stimuli. Na v 1.7CT-TAT was injected into mice (intraperitoneally [i.p.], four injections, once per hour). Co-IP experiments showed that the applied Na v 1.7CT-TAT reduced the FGF13/Na v 1.7 interaction in the afferent fibers in the dorsal spinal cord, but not in the DRG ( Figure 7A ). It is possible that the abundant amount of FGF13 and Na v 1.7 in the DRG veiled the interfering effects of Na v 1.7CT-TAT. The Na v 1.7CT-TAT treatment dose-dependently extended the response latency in the 52 C tail-flick tests ( Figure 7B ). Such an effect reached a peak level at $4-6 hr after the last injection. Thus, heat nociception is impaired by the disruption of FGF13/ Na v 1.7 interaction. À/Y mice selectively lost responsiveness to noxious heat but remained responsive to other stimulus modalities such as innocuous temperatures and noxious mechanical stimuli. Moreover, FGF13-deficient small DRG neurons exhibited AP firing that rapidly stopped when the temperature was above 43 C. Therefore, FGF13 is selectively required for the transmission of noxious heat stimuli.
TRPV1 and TRPV2 expressed in small DRG neurons have been considered as high-temperature sensors (>42 C and >52 C, respectively), while TRPM8 and TRPA1 as low-temperature sensors (25 C-28 C and 12 C-24 C, respectively) (Dhaka et al., 2006) . Studies with TRPV1-deficient mice show that TRPV1 contributes mainly to the development of inflammationinduced thermal hyperalgesia and only partially to heat-induced nociceptive responses at high temperatures (>52 C) (Caterina et al., 2000; Davis et al., 2000) . We found that heat nociception mice, the number of heat-sensitive DRG neurons did not decrease, but AP firing was not sustained as the temperature reached noxious heat levels, indicating a distinct role of FGF13 in heat nociception.
We propose a model for noxious heat sensation ( Figure 7C ), which may require two processes. First, heat stimuli activate thermosensors, such as TRPV1, to induce a cation influx, depolarize the membrane potential, and initiate APs. Second, the FGF13/Na v 1.7 complex acts as a booster that keeps persistent AP firing during noxious heat stimulation (>43 C). Several thermosensors have been reported, such as TRPV1, TPRM3, Ano1, and K 2P channels (Caterina et al., 2000; Cho et al., 2012; Davis et al., 2000; No€ el et al., 2009; Vriens et al., 2011) . They are expressed in different types of MHNs and are likely to be redundant in function so that a considerable number of heatsensitive DRG neurons and partial nociceptive behavior are gesting that this mechanism is highly efficient. The detection of intrathecally injected GST-FGF13B-TAT in the DRG and skin suggests that the exogenous FGF13 could act at the peripheral nerve ending, although the transport mechanism is unclear.
Furthermore, FGF13 was widely distributed in different types of MHNs (Li et al., 2016) ; thus, FGF13 could be a commonly used regulator in nociceptors. Taken together, heat nociception requires the FGF13/Na v 1.7 complex through a distinct mechanism from thermosensors.
Heat-Facilitated FGF13/Na v 1.7 Interaction Is a Selective Mechanism of Na v 1.7 for Heat Nociception Na v 1.7 is important for both noxious heat and mechanical sensations. The gain-of-function mutations of Na v 1.7 lead to severe thermal hyperalgesia in humans (Dib-Hajj et al., 2013) , whereas the loss-of-function mutations result in a complete loss of (C) A proposed model of the mechanism for noxious heat sensation. During heat stimulation, thermosensor activation in MHNs leads to cation influxes and initiates AP firing. The heat-facilitated FGF13/Na v 1.7 interaction stabilizes Na v 1.7 in the plasma membrane (PM) to sustain AP firing. A lack of FGF13 reduces the number of Na v 1.7 in the PM and the heat-induced AP firing and impairs heat nociception. The data are shown as mean ± SEM; *p < 0.05 and ***p < 0.001 versus the indicated group.
sensitivity to noxious stimuli (Cox et al., 2006; Dib-Hajj et al., 2013) . The loss of Na v 1.7 in mice attenuates acute pain and inflammation-and burn injury-induced thermal hyperalgesia (Minett et al., 2012; Nassar et al., 2004; Shields et al., 2012; Yeomans et al., 2005) . Na v 1.7 also contributes to mechanical nociception in mice (Nassar et al., 2004 (Nassar et al., , 2005 . TTX-resistant (TTX-R) Na v 1.8 and Na v 1.9 are expressed in nociceptive neurons (Dib-Hajj et al., 2010; Tate et al., 1998) . However, Na v 1.8-or Na v 1.9-deficient mice show little change in nociceptive thresholds and mild deficits in the inflammatory hypersensitivity (Akopian et al., 1999; Amaya et al., 2006; Leo et al., 2010; Priest et al., 2005) . Therefore, Na v 1.7 plays a major role among the sodium channels in nociception.
It is notable that a lack of Na v 1.7 causes a partial loss of heat nociception in mice, in contrast with the complete loss in humans (Cox et al., 2006; Nassar et al., 2004) . This difference may be attributed to the compensatory adaptation via other sodium channels in mice. For example, Na v 1.7 and Na v 1.8 might coordinate because both the Na v 1.7 expression and the TTX-S sodium current density increase in Na v 1.8 null mice (Akopian et al., 1999) , and the noxious heat threshold is doubled in the Na v 1.7 and Na v 1.8 gene double-knockout mice (Nassar et al., 2005) . Interestingly, the compensatory increase of Na v 1.8 protein was detected in the FGF13-deficient DRGs. However, we did not find compensatory effects of Na v 1.8 in Fgf13
À/Y mice, consistent with a report showing no TTX-R sodium current compensation for the Na v 1.7 deficiency (Nassar et al., 2004) . The loss of noxious heat sensation in Fgf13 À/Y mice was more prominent than that in both the Na v 1.7 null mice and the Na v 1.7 and Na v 1.8 double-knockout mice, indicating that the FGF13 function cannot be compensated. The loss of heat nociception, but not noxious mechanical sensation, in Fgf13 À/Y mice suggests that the heat-facilitated FGF13/Na v 1.7 interaction could be a selective mechanism in MHNs for noxious heat sensation, although Na v 1.7 itself does not have the specificity and selectivity of sensory modalities. It is possible that noxious heat condition leads to conformational changes of Na v 1.7 and therefore instable membrane localization. The facilitated interaction with FGF13 may stabilize the conformation and membrane-localization of Na v 1.7 during the heat stimulation. Taken together, the interaction with Na v 1.7 acts as a major mechanism for the FGF13 function in heat nociception, although other mechanisms might be involved in this process.
Brain Regions Specifically Activated by Noxious Heat Stimuli Are Identified
As pain is a complex experience that involves both sensory and emotional changes (Zhuo, 2016) , we further explored how the peripheral loss of noxious heat sensation affected the brain activities. The present study demonstrates that the loss of noxious heat-induced behavior in Fgf13 À/Y mice directly correlates with the loss of noxious heat-evoked fMRI signals in the brain regions. Some of the regions are known to be involved in pain perception (Becerra et al., 2011) , including the regions mediating sensorydiscriminative and affective-motivational aspects of nociceptive information, such as the MD and PF of thalamus and the S1, S2, and insular cortices. Moreover, the reduced fMRI signals of the Amyg, HPC, CPu, and RSG in Fgf13 À/Y mice provide direct evidence that the limbic system and regions involved in memory and emotional reaction are also related to noxious heat information processing. Notably, the reduction in noxious heat responses varied among different brain regions, suggesting that the different ascending nociceptive pathways are distinctively affected by the lack of FGF13 in DRG neurons. In addition, we detected the reduced response to heat stimuli in the PAG, which is a key region for descending modulation of pain. Thus, the present study has identified the brain regions that process and integrate the peripheral noxious heat inputs.
Potential Roles of FGF13 in Pathological Sensory Disorders
We show that the thermal hyperalgesia induced by peripheral tissue inflammation was also abolished in Fgf13 À/Y mice.
The loss of heat nociception in inflammatory conditions may be related to a reduction in cell-membrane-localized Na v 1.7, which contributes to inflammation-induced thermal hyperalgesia (Minett et al., 2012; Nassar et al., 2004; Yeomans et al., 2005) . Because the expression of FGF13 and Na v 1.7 in DRG neurons is decreased after peripheral nerve injury (Kim et al., 2002; Li et al., 2002; Xiao et al., 2002) , FGF13 could be mainly involved in inflammatory pain, but not in neuropathic pain. Furthermore, FGF13 regulates brain development, and its gene mutations in humans could cause X-linked intelligence disability (ID) and genetic epilepsy and febrile seizures plus (GEFS + ) (Puranam et al., 2015) . Patients with Fgf13 mutations may also suffer from sensory disorders, e.g., presumably a lack of sensitivity to noxious heat stimuli, if the mutations would cause a marked reduction of FGF13 in sensory neurons. Therefore, somatosensory tests in these patients would extend our understanding of these diseases and their pathological mechanisms and help us to protect these patients from potential harms.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS Animals
Experiments were performed according to the guidelines of the Committee for Research and Ethical Issues of the International Association for the Study of Pain and were approved by the Committee of Use of Laboratory Animals and Common facility, Institute of Neuroscience, the Chinese Academy of Sciences. Mice were raised together with littermates in pathogen-free environment and their health status was routinely checked. No more than 5 mice were housed in one cage. Food and water were provided ad libitum. Mice were maintained in a 12-hr light/dark cycle at 22 C-26 C. Experiments were conducted during the light phase of the cycle. 2-to 4-month-old male mice were used for all in vivo and in vitro experiments.
We generated the conditional knockout mice lacking FGF13 specifically in small DRG neurons. The FGF13 gene is located in the X chromosome. We made the Fgf13-loxP mice by flanking its exons 2 and 3 which encode the FGF13 core region with loxP sequences. The FGF13 gene was deleted selectively in DRG neurons by crossing Fgf13-loxP mice with BAC transgenic mice expressing Cre recombinase controlled by promoter elements of the Na v 1.8 gene, which is mainly expressed in small DRG neurons (SNS-Cre). This gene deletion mediated by SNS-Cre started at the perinatal stage, thereby minimizing the risk of developmental defects. The Fgf13 conditional knockout mice were viable and fertile and did not exhibit visible abnormalities. Then, experiments were performed with the Fgf13 knockout mice (Fgf13 À/Y ) and the control Fgf13-loxP mice (Fgf13 F/Y ). Trpv1 À/À mice were purchased from the Jackson Laboratory. C57BL/6J mice purchased from Shanghai Laboratory Animal Center, Chinese Academy of Sciences (Shanghai, China).
METHOD DETAILS Plasmid Construction
All primers and oligonucleotides used for the construction of plasmids expressing FGF13B and FGF13B truncations, GST-FGF13B, Na v 1.7, Na v 1.8, CD8a-Na v 1.7CT, GST-Na v 1.7CT fragments, GST-flag-Na v 1.7CT-TAT and GST-FGF13B-TAT are listed in Table S1 . The cDNA of mouse FGF13B was cloned into pCAG-IRES-EGFP, pcDNA3.1/myc-his(-) and pGEX vectors for the expression of FGF13B (with a separately expressed EGFP), FGF13B (full-length)-myc and GST-FGF13B, respectively. The plasmids expressing FGF13B D1-37 -myc, FGF13B D38-75 -myc, FGF13B
D76-99
-myc, FGF13B
D100-145
-myc and FGF13B D146-192 -myc were modified from the FGF13B (full-length)-myc plasmid using the KOD-plus Mutagenesis Kit (Toyobo). The cDNA of human Na v 1.7 was constructed in a pcDNA3.1-mod vector (Klugbauer et al., 1995) , and a flag tag was inserted into the C terminus of Na v 1.7 using the KOD-plus Mutagenesis Kit (Toyobo). Full length Na v 1.8 was cloned into pEGFP-N3 vector and the GFP tag of pEGFP-N3 vector was replaced by a myc tag (Zhang et al., 2008) . The C terminus (5248-5931 bp) of human Na v 1.7 (Na v 1.7CT) following a flag tag was cloned into a pGEX vector for the construction of the GST-flag-Na v 1.7CT plasmid. The plasmids expressing GST-flag and the GST-flag-Na v 1.7CT fragments (f1-f9) were modified from the GST-flag-Na v 1.7CT plasmid by deletion using the KOD-plus Mutagenesis Kit (Toyobo). Glycine10-TAT was made by oligonucleotides denaturing and annealing. The Glycine10-TAT sequence was inserted into the C terminus of GST-flag-Na v 1.7CT and GST-FGF13B for the construction of the GST-flag-Na v 1.7CT-TAT and GST-FGF13B-TAT plasmids, respectively. The GST-flag-TAT plasmid was made from the GST-flag-Na v 1.7CT-TAT plasmid by deletion using the KOD-plus Mutagenesis Kit (Toyobo). The Na v 1.7CT sequence was cloned into a pMyc-CD8a construct (Zhang et al., 2008) . The rat CD8a sequence on the N terminus was used to anchor Na v 1.7CT to the cell membrane.
Cell Culture and Transfection HEK293 cells were cultured in MEM with 10% fetal bovine serum. The cells were transfected with 1-2 mg plasmid per 35-mm dish or 2-3 mg plasmid per 60-mm dish using Lipofectamine 2000 reagent (Invitrogen). The cells were used for the following experiments 24-48 hr after transfection. DRGs from 2-to 4-month-old mice were carefully isolated and digested in oxygenated DMEM containing collagenase (0.4 mg/mL), trypsin (1 mg/mL) and DNase (0.1 mg/mL) for 30 min at 37 C. After gentle trituration, dissociated cells were plated onto poly-D-lysinecoated glass coverslips in DMEM/F12 (1:1) media supplemented with 100 U/mL penicillin, 0.1 mg/mL streptomycin and 10% fetal bovine serum.
Morphology Analysis 2-to 4-month-old mice were perfused with 4% paraformaldehyde (PFA). The lumber (L) 4-5 DRGs and spinal cord were dissected and post-fixed in 4% PFA for 2 hr. Then the tissues were dehydrated and embedded for cryostat sectioning. The cryostat sections were incubated in primary antibodies at 4 C overnight, and then incubated in secondary antibodies at 37 C for 45 min. Skin immunostaining was performed with non-perfused mice. The glabrous skin of mouse hindpaw was dissected and fixed in Zamboni's fixative [2% formaldehyde, 15% saturated picric acid, 0.1 M phosphate buffer (pH 7.3)] for 18 hr at 4 C. The cryostat sections at 30 mm were placed in phosphate-buffered saline (PBS) with 0.1% Triton X-100 and stained as free floating sections. The primary antibodies against FGF13 (1:3000, Go; Santa Cruz Biotechnology), CGRP (1:1000, Rb; DiaSorin), PGP9.5 (1:1000, Rb; Ultraclone), tuj1 (1:1000, Chicken; Abcam) and Na v 1.8 (1:500, Rb; Alomone Labs) were used. The secondary antibodies were FITC, Cy3 or Cy5-conjugated donkey against goat, rabbit or chicken antibodies (1:100; Jackson ImmunoResearch). Fluorescein-labeled IB4 (1:200; Vector Laboratories) stained the sections at 37 C for 45 min. Free floating sections were counterstained with Hoechst 33258 (1:5000; Sigma-Aldrich) at room temperature for 15 min.
For whole-mount DRG immunostaining, L5 DRGs were dissected and fixed in 4% PFA at 4 C overnight. The DRGs were washed and penetrated with 0.3% Triton X-100 in PBS every one hour for 5 hr. Then the tissues were incubated with primary antibodies in blocking solution (75% 0.3% PBST, 20% DMSO and 5% Donkey Serum) for 4 d and then were washed with 0.3% Triton X-100 in PBS every one hour for 5 hr. The tissues were incubated with secondary antibodies in blocking solution for 2 d and then washed with 0.3% Triton X-100 in PBS every one hour for 5 hr. All the washing and incubation procedures were performed on a rocking platform at room temperature. The tissues were dehydrated in methanol for 1 hr and cleared in Benzyl Alcohol: Benzyl Benzoate 1:2. The tissues were mounted in Benzyl Alcohol/Benzyl Benzoate and the images were acquired using Leica SP8 confocal microscope. The total cell number of DRGs was manually counted with ImageJ cell counter tool.
Nissl staining was performed with 0.1% cresyl violet acetate solution. The sections were stained in cresyl violet acetate solution for 5-10 min at 37 C, rinsed in water, dehydrated in 70, 95 and 100% ethanol, cleared in xylene and finally mounted for observation. To examine the ultrastructure of the spinal cord, we fixed the mice with 4% PFA and 0.05% glutaraldehyde, and dissected the lumbar spinal cord. The vibratome sections of the lumbar spinal cord were post-fixed in 0.5% osmium tetroxide and embedded in Epon 812. The ultrathin sections of the spinal cord dorsal horn were examined with an electron microscope.
Immunoblotting
The cerebral cortex, cerebellum, thalamus, hippocampus, DRG, spinal cord, dorsal root, sciatic nerve and plantar skin tissues from adult mice were dissected and homogenized. The tissue homogenates and cultured cells were lysed with RIPA buffer [50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 0.1% Triton X-100, 10% glycerol, 0.05% bovine serum albumin, 1 mM PMSF, 10 mg/mL aprotinin, 1 mg/mL pepstatin and 1 mg/mL leupeptin] or [10 mM HEPES (pH 7.5), 10 mM NaF, 120 mM NaCl, 5 mM EDTA, 1% Triton X-100, 1 mM PMSF, 10 mg/mL aprotinin, 1 mg/mL pepstatin and 1 mg/mL leupeptin]. The denatured samples were loaded for SDS-PAGE, transferred, probed with antibodies and visualized with enhanced chemiluminescence. The antibodies against FGF13 (1:500, Go), FGF13 (1:5000, Rb; made by immunization with the C terminus of FGF13B 182-192 aa), Na v 1.7 (1:500, Mo; Millipore), Na v 1.8 (1:500), Na v 1.6 (1:500, Rb; Millipore), Na v 1.9 (1:500, Rb; Alomone Labs), TRPV1 (1:500, Go, Santa Cruz Biotechnology), actin (1:100000, Mo; Chemicon), transferrin receptor (1:500, Mo; Invitrogen), flag (1:2000, Mo; Abmart), myc (1:1000, Mo; Developmental Studies Hybridoma Bank), TRPV2 (1:500, Go; Sigma-Aldrich), GST (1:500, Go; Amersham Pharmacia Biotech), pan-cadherin (1:2000, Rb, Cell Signaling Technology), HSP90 (1:2000, Rb, Cell Signaling Technology) were used. We also stained the SDS-PAGE gels and immunoblotting membranes with Coomassie brilliant blue R-250 (Sangon Biotech) (0.25% solution in methanol: water: acetic acid 5:4:1) and Ponceau S (Sangon Biotech) (0.5% solution in 1% acetic acid), respectively, to show the GST-fused proteins.
Preparation of the GST-Fused Proteins
The GST-fused proteins were expressed in Escherichia coli BL21. The bacteria were grown in 2 3 YTA media and the protein expression was induced by 1 mM Isopropyl b-D-thiogalactopyranoside (IPTG). Then the bacteria were centrifuged, resuspended and sonicated for the protein release. The proteins were purified using Glutathione-Sepharose beads (GE Healthcare), concentrated and quantified before use.
Immunoprecipitation and GST Pull-Down
The cultured cells or dissected tissues were lysed in ice cold RIPA buffer. The lysate was centrifuged and 5% of the supernatant was taken for a whole-cell lysate sample. The remaining supernatant was precipitated with 1-5 mg of antibody at 4 C overnight and afterward protein G beads (Roche) at 4 C for 2 hr. The immunoprecipitated sample was denatured and prepared for immunoblotting. The immunoprecipitation was performed with antibodies against FGF13 (Go), FGF13 (Rb), GST (Go, Amersham Pharmacia Biotech) and myc (Rb, Sigma-Aldrich). The GST-fused protein (5 mg) was incubated with the cell lysate at 4 C overnight. Then, the GST-fused protein was precipitated with 10 mL of Glutathione-Sepharose beads at 4 C for 2 hr. The precipitant was washed, denatured and prepared for immunoblotting. To detect the direct interaction between FGF13 and Na v 1.7CT, we prepared purified FGF13B by removing GST from GST-FGF13B using thrombin (Sigma-Aldrich). The GST-FGF13B slurry (100 mL, $1 mg/mL) was digested with 0.02 units of thrombin at room temperature for 12 hr. The GST and undigested GST-FGF13B proteins were attached with the beads and were removed by centrifugation. Then, the purified FGF13B protein was collected from the supernatant. We incubated 10 mL of supernatant (diluted in 400 mL of RIPA buffer) with 5 mg of GST-flag-Na v 1.7CT or the GST-flag-Na v 1.7CT fragments for the detection of their direct interaction.
To test the effect of heat stimulation on the FGF13/Na v 1.7 interaction, we collected HEK293 cells co-transfected with FGF13B and Na v 1.7, and added DSS (Thermo Fisher Scientific) to the cell suspension shortly before or after the heat stimulation (43 C for 1 min) to chemically crosslink the FGF13 and Na v 1.7 that interacted during the heat stimulation. The reaction was stopped after 45 min incubation at 4
C. The cells were collected and mildly lysed with Permeabilization Buffer (MEM-Per Plus Kit, Thermo Fisher Scientific). The cytosol component was separated from the supernatant after centrifugation. The pellet (enriched membrane component) was further lysed with crosslinking RIPA buffer [50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1% Triton X-100, 1% sodium deoxycholate, 0.1% SDS, 1 mM PMSF, 10 mg/mL aprotinin, 1 mg/mL pepstatin and 1 mg/mL leupeptin]. The high detergent condition in crosslinking RIPA buffer effectively prevented interaction between free FGF13 and Na v 1.7 so that only the FGF13 and Na v 1.7 crosslinked with covalent bond was detected. After the incubation with FGF13 antibody and protein G beads, the proteins attached to the protein G beads were washed repeatedly to further remove the freely bound Na v 1.7. In this way, we uncovered the FGF13/Na v 1.7 interaction regulated by the heat stimulation.
Cell Surface Biotinylation
Cultured cells were dissociated using trypsin and incubated in Ca 2+ /Mg 2+ PBS. The cells were transferred into a small volume of 100 mL per tube for rapid heating. The cells were treated with or without noxious heat stimulation and then were cooled on ice immediately. Sulfo-NHS-LC-Biotin (Pierce Protein Biology) was added into each cell suspension at a working concentration of 0.25 mg/mL. The biotinylation reaction was stopped after 45 min of incubation at 4 C. Then, the cells were lysed with RIPA buffer, and 5% of the lysate was used as a whole-cell lysate sample and the remaining lysate was precipitated with streptavidin-agarose beads (Pierce Protein Biology) overnight at 4 C. The precipitated sample was denatured and prepared for immunoblotting. In the crosslinking assay, DSS (Thermo Fisher Scientific) was added to the cell suspension shortly before or after heat stimulation. The cell suspension was crosslinked at 4 C for 10 min. Then, the cells were biotinylated, lysed, precipitated and processed for immunoblotting.
Genotyping
The Fgf13 conditional knockout mice were identified by genotyping. A small piece of mouse tail or toe was digested in Proteinase K buffer. The genomic DNA was extracted with phenol/chloroform, precipitated with isopropanol, washed with 75% ethanol and dissolved in water. The mouse genotype was then identified by PCR. The primers for the identification of 
Behavioral Tests
Behavioral tests were performed with 2-to 4-month-old male mice. In the tail-flick, Hargreaves and hot plate tests, the response latency to nociceptive stimuli was measured. In von Frey and Randall-Selitto test, the threshold of nociceptive responses was measured. The tests above were stopped at a cutoff time or force for animal protection. In evaporative cooling and formalin test, the duration of nociceptive responses was measured.
The Tail-Flick Test The tail of mouse was immersed in a water bath at 48 C, 50 C or 52 C. The cutoff time was 20 s, 15 s, or 10 s, respectively. The Hargreaves Test Mice were habituated in plastic chambers, and radiant light was applied to one of their hindpaws. The radiant light was applied when the mice were resting quietly and was stopped immediately after the movement of the hindpaw. In the inflammatory pain model, 20 mL of CFA was intraplantarly injected into one hindpaw of each mouse, and we tested the noxious heat responses using Hargreaves test when applied radiant heat to the hindpaw with CFA injection.
The Hot Plate Test
Mice were put on a hot plate at a temperature of 50 C, 52 C or 55 C, and the cutoff time was 70 s, 50 s or 30 s, respectively.
The von Frey Test
The mice were habituated in plastic chambers on a mesh floor. The von Frey filaments with forces of increasing grades were applied to the mice hind paw. One filament was applied 5 times in a round of testing. The filament force evoking paw withdrawals for more than 3 times in a round of testing was defined as the mechanical threshold. The cutoff force was 4 g. To prepare the neuropathic pain model induced by spared nerve injury (SNI), we transected the common peroneal and tibial branches of the right sciatic nerve with $1 mm of nerve removed and left the sural nerve intact. The von Frey test was performed on the lateral part of the right plantar surface where the sural nerve innervates. The Randall-Selitto Test A gradually increasing pressure was applied to the mouse tail. The pressure force causing a tail withdrawal was defined as the mechanical threshold. The cutoff force was 200 g.
The Evaporative Cooling Test
The mice were habituated in a plastic chamber on a mesh floor. A drop (10-20 mL) of acetone was applied to the mice hind paw with 1 mL syringe. The duration of the flinching or licking behavior within 1 min was measured.
The Rotarod Test
The mice were tested on a rotarod with the velocity increasing from 4 rpm to 40 rpm within 5 min. The mice were pre-trained for 2 d for adaptation. Then the duration time on the rotarod before the mice fell off was recorded.
The Open Field Test
The mice were put in an open field (45 3 45 cm) and their locomotor activities within 30 min were recorded and analyzed. The total moving distance and the moving velocity were measured for the evaluation of the locomotor activity. The Two-Temperature Choice Test In the two-temperature choice test, two cold/hot plates (20 3 20 cm each) were joined together. The plates were divided into two 40 3 10 cm lanes in which the mice were free to move. The behavior of mice was recorded for 10 min in each round of test, and the time they spent on each plate was analyzed.
The Formalin Test
The 2% formalin diluted in saline was injected into the plantar skin of left hindpaw of the mouse. The spontaneous nociceptive responses were recorded and analyzed. The duration of licking or biting behavior was counted for 1 hr in 5 min interval. The first phase of nociceptive responses was analyzed during 0-10 min, and the second phase of nociceptive responses was analyzed during 10-60 min.
Infusion of Na v 1.7CT-TAT and FGF13B-TAT GST-flag-Na v 1.7CT-TAT (Na v 1.7CT-TAT) was used for disruption of the FGF13/Na v 1.7 interaction. Na v 1.7CT-TAT was dissolved in elution buffer (50 mM Tris-HCl, pH 8.0) and was injected intraperitoneally for 4 times (one injection an hour) before the behavioral tests. Co-IP was used to test whether Na v 1.7CT-TAT was able to disrupt the FGF13/Na v 1.7 interaction. The tissues were collected 4-5 hr after the injections when Na v 1.7CT-TAT was most effective in the behavioral tests. To test the rescue effects of GST-FGF13B-TAT on the behavioral deficits, we dissolved GST-FGF13B-TAT in the elution buffer and injected it intrathecally (i.t.) into Fgf13 À/Y mice. Then the behavioral tests were performed at the set time points. We performed the co-IP experiments with mouse DRG or spinal cord tissues collected at 20 min, 1 hr and 2.5 hr after GST-FGF13B-TAT injection (i.t.) to detect whether the rescue effects in the behavioral tests were correlated with the interaction of exogenous FGF13B and Na v 1.7. These time points (20 min, 1 hr and 2.5 h) corresponded to the most effective stage and the decaying stage of the GST-FGF13B-TAT effects in the behavioral tests. The vehicle (elution buffer) did not cause apparent changes in nociceptive behaviors when injected either intraperitoneally or intrathecally.
Preparation of an FGF13 Antibody
A peptide mapping at the C terminus of FGF13B (182-192 aa) was prepared and chemically conjugated with the immunogenic carrier protein keyhole limpet hemocyanin (KLH). The conjugated peptide was mixed with Freund's complete adjuvant and used to immunize New Zealand rabbits. The immunizations were repeated 3 weeks and 5 weeks later. The sera were taken and stored at À70 C. The antibody efficiency was validated in HEK293 cells transfected with FGF13 plasmids and the DRG tissue samples. The antibody specificity was verified by a pre-absorption assay.
Electrophysiological Recording
All chemicals used in the electrophysiological experiments were purchased from Sigma-Aldrich. The voltage and current electrophysiological data were analyzed using Clampfit 10.3 (Axon instruments), Origin pro 8.6.0 (Microcal) and PRISM (GraphPad Software).
Voltage-Clamp Recording
For sodium currents recording, small DRG neurons cultured for 12-24 hr or HEK293 cells transfected with the indicated plasmids were used for voltage-clamp recordings. Patch pipettes with 1-2 MU resistance were prepared using a puller (P-97 Sutter Instrument). The pipette solution contained (in mM): 140 CsF, 10 NaCl, 1 EGTA, 10 dextrose and 10 HEPES, pH 7.3 (adjusted with CsOH). The bath solution for DRG neurons was (in mM): 30 NaCl, 110 choline chloride, 3 KCl, 1 MgCl 2 , 1 CaCl 2 , 20 TEACl, 5 CsCl, 0.1 CdCl 2 and 10 HEPES, pH 7.3 (adjusted with NaOH). The bath solution for HEK293 cells was (in mM): 140 NaCl, 3 KCl, 1 MgCl 2 , 1 CaCl 2 and 10 HEPES, pH 7.3 (adjusted with NaOH). The whole-cell configuration was obtained in voltage-clamp mode using an Axopatch 700B amplifier (Molecular Devices). Data were acquired via a Digidata 1440 A/D converter (Molecular Devices) at 50 kHz and filtered at 10 kHz. Voltage errors were minimized with 80%-90% series resistance compensation, and linear leak currents and capacitance artifacts were subtracted out using the P/6 method.
In both HEK293 cells transfected with Na v 1.7 and DRG neurons, sodium currents were evoked by 100-ms pulses from a holding potential of À100 mV to a range of depolarizing steps (À90 to +50 mV in 5-mV increments). For DRG neurons, we used 1 mM TTX in the bath solution to isolate the TTX-S currents. The TTX-S currents were obtained by the subtraction of the sodium currents obtained before and after TTX treatment. DRG neurons were held at À100 mV to recover the majority of TTX-S channels from inactivation. DRG neurons with Na v 1.9 currents were excluded from the data analysis. The peak current induced by each depolarizing potential was plotted into I-V curves. Activation curves were obtained by calculating conductance (G) at each voltage (V) using the equation G = I/(V -V rev ) with V rev being the calculated reversal potential. Activation curves were fitted with the Boltzmann distribution equation as follows: G = ðG max =1 + e ðV 1=2;act ÀV=kÞ Þ, where G max is the maximal sodium conductance, V 1/2,act is the potential of half-maximal activation, V is the test potential and k is the slope factor.
Steady-state fast inactivation was assessed with a series of 500-ms prepulses that started from the holding potential of À100 mV, ranged from À130 mV to À10 mV in 5-mV increments, and were followed by a 100-ms depolarization to À10 mV. The peak inward currents were normalized to the maximal peak current (I max ). The normalized curves were fitted with a Boltzmann distribution equation: I=I max = ð1=1 + e ðVmÀV 1=2;inact =kÞ Þ, where V m is the preconditioning pulse potential and V 1/2, inact is the potential of half-maximal inactivation.
The sodium currents of DRG neurons in innocuous temperature and noxious heat condition were recorded. The sodium currents were evoked by 100-ms pulses from a holding potential of À100 mV to a range of depolarizing steps (À90 to +50 mV in 10-mV increments). The recording started when the bath solution had been adjusted to the set temperatures.
For the recording of capsaicin-induced currents, dissociated small DRG neurons were held at À70 mV. Pipettes solution contained (in mM): 135 K gluconate, 0.5 CaCl 2 , 2 MgCl 2, 5 KCl, 5 EGTA and 5 HEPES (pH 7.4). The bath solution contained (in mM): 150 NaCl, 5 KCl, 1 MgCl 2 , 2.5 CaCl 2 and 10 HEPES, 10 D-glucose (pH 7.3). Inward currents induced by 1 mM capsaicin for 30 s were recorded. Current-Clamp Recording Pipettes (2-3 MU) were filled with solution contained (in mM) 140 KCl, 0.5 EGTA, 5 HEPES and 3 Mg-ATP, adjusted to pH 7.3 with KOH. The bath solution contained (in mM): 140 NaCl, 3 KCl, 2 MgCl 2 , 2 CaCl 2 and 10 HEPES, pH 7.3, adjusted with NaOH. A wholecell configuration was obtained at room temperature in voltage-clamp mode with a holding potential of -70 mV and then the recording was performed after switching to current-clamp mode. Only the cells with stable resting potentials below À40 mV were used in this study. The data were filtered at 5 kHz and digitized at 20 kHz.
APs induced by heat stimulation were recorded in current-clamp mode at temperatures ranging from room temperature (22 C-25 C) to noxious heat levels (45 C-49 C). If the increasing temperature evoked AP firing in a small DRG neuron, the neuron was considered a heat-sensitive neuron. As duration of heat exposure might also affect AP firing, we tried to differentiate whether the decreased AP amplitude was caused by noxious heat stimulation or the duration of heat exposure. We held the temperature between 42 C and 43 C, but not above 43 C. We found the AP amplitude barely decreased after 10 s heat (42 C-43 C) exposure (Fgf13 87.5% ± 2.7%, n = 23; Fgf13 À/Y 84.8% ± 4.6%, n = 12). In comparison, when treated with noxious heat (> 43 C), most Fgf13 À/Y neurons exhibited dramatic AP amplitude decrease within 10 s treatment. So the decreased AP amplitude was mainly caused by noxious heat stimulation but not extending heat exposure. In order to test the rescue effects of GST-FGF13B-TAT, we treated DRG neurons from Fgf13 À/Y mice with 1 mM GST-FGF13B-TAT or GST-TAT for 2 hr. To disrupt the endogenous FGF13/Na v 1.7 interaction, we incubated DRG neurons from C57BL/6J mice with 1 mM GST-flag-Na v 1.7CT-TAT or GST-flag-TAT for 30 min. For each heat-sensitive DRG neuron, we counted the number of AP spikes within one degree as the temperature increased. The analysis of AP spike numbers revealed the AP distribution within the temperature ranging from 38 C to 45 C. We depicted the change of AP amplitudes using a fitting curve of the AP amplitudes from 38 C to 45 C. The change of AP amplitudes in noxious heat stimulation was also quantified by the ratio of the AP amplitude at 45 C to that of the first AP. We also recorded the APs induced by 50-ms current injections starting from 50 pA in 5-pA increments before and after heat stimulation to make sure that the neurons were healthy and did not lose responsiveness.
Temperature Control
The temperature of perfusion solution was controlled by a TC-344B (Warner Instruments). The temperature was increased gradually from room temperature to the maximal temperature in 80-120 s.
Recoding of Spinal Cord sEPSC
We recorded the spontaneous excitatory postsynaptic currents (sEPSCs) in spinal cord laminae II. Vibratome sections of the mice lumbar spinal cord were perfused with oxygenated Krebs' solution (in mM: 117 NaCl, 3.6 KCl, 2.5CaCl 2 , 1.2 MgCl 2 , 1.2 NaH 2 PO 4 , 25 NaHCO 3 and 11 D-glucose). The pipette solution contained (in mM) 135 K-gluconate, 0.5 CaCl 2 , 2 MgCl 2 , 5 KCl, 5 EGTA, 5 HEPES and 5 D-glucose. Each neuron was recorded by a whole-cell patch-clamp for 15 min. The frequency and amplitude of sEPSC were analyzed by Axograph (Molecular Devices).
Dual Fluorescent In Situ Hybridization
The probes for the detection of mouse FGF13 and Na v 1.7 mRNAs were amplified from the mouse cDNA by PCR. The primers producing mouse Na v 1.7 probe were 5 0 -GAGGACCTGGACCCATAC-3 0 and 5 0 -TGAGTCATTAGCCGAAAC-3 0 . The primers producing mouse FGF13 probe were 5 0 -TCGCTCATCCGGCAAAAGAG-3 0 and 5 0 -GGTTCTGTTATAGAGCCCTC-3 0 . The primers producing mouse Na v 1.8 probe were 5 0 -AATCTGGGGAGTTGGATTCTCT-3 0 and 5 0 -ATGTGTCTCTGGAAGTCCTGGT-3 0 . For the dual labeling of FGF13 and Nav1.7, the probe for FGF13 mRNA was labeled with digoxigenin (DIG) and the probe for Na v 1.7 mRNA was labeled with fluorescein (FITC). For the dual labeling of Na v 1.7 and Na v 1.8, the probe for Na v 1.7 mRNA was labeled with digoxigenin (DIG) and the probe for Na v 1.8 mRNA was labeled with fluorescein (FITC). The cryostat sections of the fresh DRG tissue were fixed with 4% PFA in Diethy Pyrocarbonate (DEPC)-PBS for 20 min, then acetylated and prehybridized in hybridization buffer at 67 C for 3 hr. Then, the sections were incubated in the hybridization buffer containing the antisense probes (1 mg/mL of each probe) at 67 C for 16 hr. After hybridization, the sections were washed, blocked and incubated with anti-FITC-horseradish peroxidase (HRP) (1:4000, Roche) at 4 C overnight and then treated with tyramide signal amplification (TSA)-plus 2,4-dinitrophenyl (DNP) reagents (1:100, PerkinElmer) for 10 min. Then the sections were incubated with anti-digoxigenin alkaline phosphatase (anti-DIG-AP) (1:1000, Roche) and anti-dinitrophenyl Alexa488 (anti-DNP Alexa488) (1:500, Molecular Probes) in the blocking buffer at 4 C overnight. The sections were washed and then developed with 2-hydroxy-3-naphtoic acid-2 0 -phenylanilide phosphate/Fast Red (HNPP/FR) (1:100, Roche).
fMRI Experiment
For fMRI scans, mice were sedated and mechanically ventilated using light isoflurane anesthesia (0.7%-1%) delivered with O 2 :N 2 70:30. Each anesthetized mouse was placed in a custom-designed magnetic resonance cradle with the head secured by ear and bite bars. The cradle contained a circulating warm system for the maintenance of the core body temperature at 37.5 C-38.5 C. A pressure sensor (SA Instruments Inc) was positioned under the abdomen of the mice to monitor respiration (maintained at 80-100 breaths/min).
An advanced thermal stimulator (ATS) thermode (Medoc, ramp rate 8 C/s) was positioned on the left hind paw to deliver noxious heat stimuli. To map the neural responses, we ran nine alternations of baseline temperature (32 C, 30 s in duration) and noxious heat temperature (47.5 C, 21 s in duration) in each run. Typically, 2-3 runs were collected and each run consisted of 228 image volumes. The thermode remained in contact with the skin during the entire imaging session.
All fMRI scans were performed in a 7-Tesla small animal scanner with a 30-cm diameter bore (Bruker Biospec 7030 USR). A 4-element phased array coil was used to receive the radio frequency signal and a linear volume coil was used to transmit the radio frequency pulses. The T2-weighted (T2W) structural images were obtained using a rapid acquisition with refocused echoes (RARE) sequence [TR = 3000 ms, TE = 8.5 ms, matrix size = 192 3 128 and field of view (FOV) = 24 mm 3 16 mm]. Prior to functional image scans, a global shimming calculation of the entire brain was applied to improve the magnetic field homogeneity (MAPSHIM, Bruker). Twelve coronal functional echo planar imaging (EPI) images (in plane resolution of 0.25 3 0.25 mm 2 and 0.5 mm slice thickness) were acquired using gradient-echo echo-planar imaging (GE-EPI) sequences (FOV = 24 3 16 mm, matrix size = 96 3 64, TR = 2500 ms, TE = 13.5 ms and bandwidth 200 kHz). Fifteen sets of T2W structural images were randomly selected from the experimental groups, realigned with each other and then averaged to generate a set of reference images. For each animal, the T2W images were co-registered to the reference images using a linear image registration tool (FLIRT, FSL) for group analysis. Using the hemodynamic response function (HRF) convolved with the boxcar function of the stimulation protocol (3dDeconvolve, AFNI) as a predictor, a voxel-wise correlation analysis of fMRI signals was performed for each group (Fgf13 F/Y and Fgf13 À/Y ). Group activation maps were displayed as statistical t-value maps with warm-and cold-color indicating the increase and decrease of blood oxygen level dependent (BOLD) signals, respectively. Student's t test (3dttest++, AFNI) was used to quantify the statistical differences between the group activation maps. EPI voxels (with a minimum cluster size of 5 contiguous voxels) that exhibited significant signal differences between the two groups (p < 0.01, with a corrected false discovery rate) were included in the difference maps. Thresholded group activation maps and the difference maps were superimposed on T2-weighted structural images for display. To quantify the fMRI BOLD response magnitude to noxious heat stimuli in each group (Fgf13 F/Y and Fgf13 À/Y mice), we extracted BOLD signal time courses from the voxels in each region of interest (ROI). A mouse atlas and the statistical activation difference map were used to identify the ROIs. The BOLD signal changes (in percentage) in each ROI before and after the stimulation were calculated and averaged across the mice. The changes were compared between the two groups of mice (Fgf13 Single-Cell RNA Sequencing The detailed procedures were described previously (Li et al., 2016) . DRG neurons were digested, triturated and plated on coverslips. Then the neurons were randomly selected, picked by a glass pipette and lysed. The RNA of a single neuron was extracted for reverse transcription. The cDNA of each neuron was amplified for the construction of sequencing libraries. The cDNA libraries were used for high-coverage single-cell RNA sequencing. DRG neurons were classified into ten clusters by unsupervised hierarchical clustering analysis. The gene expression pattern in each cluster was analyzed on basis of the sequencing data.
